Literature DB >> 12419177

Hypertension and the eye.

James S Wolffsohn1, Peter G Hurcomb.   

Abstract

In addition to being the chief cause of death in developed countries, systemic hypertension is also a leading cause of visual impairment. The eye is an end arteriolar system and is therefore susceptible to changes in blood pressure. It is also the only place where blood vessels can be clearly viewed by noninvasive techniques. This paper reviews current research into premalignant and malignant retinal signs of systemic hypertension. Previous methods of classifying retinal hypertensive signs are identified, along with more recent image analysis techniques. The need for observing the retinal vasculature as well as measuring blood pressure for monitoring systemic hypertensive patients is discussed in relation to current research.

Entities:  

Mesh:

Year:  2002        PMID: 12419177     DOI: 10.1007/s11906-002-0028-z

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  49 in total

1.  Measurement and classification of retinal vascular tortuosity.

Authors:  W E Hart; M Goldbaum; B Côté; P Kube; M R Nelson
Journal:  Int J Med Inform       Date:  1999 Feb-Mar       Impact factor: 4.046

Review 2.  Medical cardiovascular treatment trials: relevant to medical ophthalmology in 1997?

Authors:  P M Dodson; E E Kritzinger
Journal:  Eye (Lond)       Date:  1997       Impact factor: 3.775

Review 3.  Ocular signs of systemic hypertension: a review.

Authors:  P G Hurcomb; J S Wolffsohn; G A Napper
Journal:  Ophthalmic Physiol Opt       Date:  2001-11       Impact factor: 3.117

Review 4.  Hypertensive retinopathy: a review of existing classification systems and a suggestion for a simplified grading system.

Authors:  P M Dodson; G Y Lip; S M Eames; J M Gibson; D G Beevers
Journal:  J Hum Hypertens       Date:  1996-02       Impact factor: 3.012

5.  Retinopathy in older persons without diabetes and its relationship to hypertension.

Authors:  T Yu; P Mitchell; G Berry; W Li; J J Wang
Journal:  Arch Ophthalmol       Date:  1998-01

6.  Acute effect of metipranolol on the retinal circulation.

Authors:  S Wolf; E Werner; K Schulte; M Reim
Journal:  Br J Ophthalmol       Date:  1998-08       Impact factor: 4.638

7.  Hypertensive retinopathy. Description, classification, and prognosis.

Authors:  J B Walsh
Journal:  Ophthalmology       Date:  1982-10       Impact factor: 12.079

Review 8.  Hypertension and the eye: applications of the Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  E C Marshall; V E Malinovsky
Journal:  J Am Optom Assoc       Date:  1998-05

9.  Fundus lesions in malignant hypertension. IV. Focal intraretinal periarteriolar transudates.

Authors:  S S Hayreh; G E Servais; P S Virdi
Journal:  Ophthalmology       Date:  1986-01       Impact factor: 12.079

10.  Fundus lesions in malignant hypertension. V. Hypertensive optic neuropathy.

Authors:  S S Hayreh; G E Servais; P S Virdi
Journal:  Ophthalmology       Date:  1986-01       Impact factor: 12.079

View more
  4 in total

Review 1.  Impact of arterial hypertension on the eye.

Authors:  Vasiliki Katsi; Maria Marketou; Charalambos Vlachopoulos; Dimitris Tousoulis; George Souretis; Nikolaos Papageorgiou; Christodoulos Stefanadis; Panos Vardas; Ioannis Kallikazaros
Journal:  Curr Hypertens Rep       Date:  2012-12       Impact factor: 5.369

2.  Hypertensive emergency presenting as blurry vision in a patient with hypertensive chorioretinopathy.

Authors:  Andrew W Stacey; Cemal B Sozener; Cagri G Besirli
Journal:  Int J Emerg Med       Date:  2015-04-23

Review 3.  Hypertensive choroidopathy.

Authors:  Karyn Bourke; Milan R Patel; L Michael Prisant; Dennis M Marcus
Journal:  J Clin Hypertens (Greenwich)       Date:  2004-08       Impact factor: 3.738

Review 4.  Impact of Arterial Hypertension on the Eye: A Review of the Pathogenesis, Diagnostic Methods, and Treatment of Hypertensive Retinopathy.

Authors:  Jacek Dziedziak; Anna Zaleska-Żmijewska; Jacek Paweł Szaflik; Agnieszka Cudnoch-Jędrzejewska
Journal:  Med Sci Monit       Date:  2022-01-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.